Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Actavis Pharma's morphine sulfate to market a generic morphine sulfate product. This action authorizes the generic f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)